Pediatric Screening

Towards a future of proactive, personalized pediatric care

Unravel the Puzzle of Your Child's Health■
Understand your child’s health on a genetic level by identifying their health risks in the early stages of life
Order Now
Consult Our Expert
Product Image
An NGS-based test for identifying genetic risk factors associated with developing inherited disorders in the pediatric population.
  • Early detection and risk prediction 
  • In-depth information on genetic variants
  • Allows timely intervention to prevent complications
  • Enables lifestyle changes to achieve the best health outcomes
Conditions / Disorders Covered:
Metabolic disorders
Metabolic disorders
Hormonal/Endocrine Disorders
Hormonal/Endocrine Disorders
Blood Disorders/ Haemoglobinopathies
Blood Disorders/ Haemoglobinopathies
Cardiac Conditions
Cardiac Conditions
Immunodeficiency Conditions
Immunodeficiency Conditions
Epilepsy
Epilepsy
Other Neurological Disorders
Other Neurological Disorders
Pediatric Cancers
Pediatric Cancers
Who Should Get Tested?
Essential for:
ALL
Kids Under 18 years
Especially for Patients with:
✦ Premature babies
✦ Babies with low birth-weight
✦ Babies/children with a family history of genetic disorders
✦ Children (0-18 years old)
Order Now
Consult Our Expert
Benefits
Benefits of DGx Pediatric Screening Test
  • Reduces diagnosis and treatment time
  • Confirms diagnosis for genetic disorders
  • Informs on treatment and management strategies
What makes DGx Pediatric Screening Test Special?
  • Expanded screening panel
  • Increased diagnostic power
  • Rapid diagnosis
  • Improved sensitivity and specificity
  • Cost-effective
  • Actionable and easy-to-interpret reports
Benefits
Test Specifications
Specimen required:
4ml EDTA-Blood
Specimen required:
Sequencing coverage:
>99.0% >20X
Sequencing coverage:
No. of genes covered:
450+
No. of genes covered:
Variant types covered:
SNPs, indels
Variant types covered:
Turnaround time:
28 Days
Turnaround time:
Guidelines followed:
ACMG & AMP
Guidelines followed:
FAQs
What is the DGx Pediatric Screening test?
What is meant by genetic screening and what does it imply?
Which technology is used for DGx Pediatric screening test?
How is this test different from the other conventional tests?
How many genes does DGx Pediatric Screening test cover?
How is the DGx Pediatric test sample collected?
When is this test typically done?
Is this test safe for children?
Will this test only identify genetic mutations related to the conditions mentioned?
What if the patient sample is sent for screening purposes?
What does a ‘Not detected’ result mean in this test?
What if the result is abnormal or any genetic mutation associated with a disease is identified?
How are the recommended actionables determined?
Is this test reliable?
Is there any need to undergo any further test after this?
What kind of diseases or disorders are addressed in this test?
Who should get tested?
Why is it important to conduct this test in children?
What can happen if such genetic tests are not done early in life?
What is the turn-around-time (TAT) for this test?
Will the samples be preserved? If yes, then what is the time-duration?
Is the database regularly updated?
Will incidental findings related to heritable diseases/ conditions other than those listed be shared in the report?
What are the advantages of this DGx Pediatric Screening test?
What information does the DGx Pediatric Report provide?
Who will have access to the report?
Will the information in the report be safe and private?